Doi, T., Iwasa, S., Muro, K., Satoh, T., Hironaka, S., Esaki, T., . . . Watanabe, M. (2018). Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: The JAVELIN Solid Tumor JPN trial. Gastric Cancer.
Style de citation ChicagoDoi, Toshihiko, et al. "Phase 1 Trial of Avelumab (anti-PD-L1) in Japanese Patients With Advanced Solid Tumors, Including Dose Expansion in Patients With Gastric or Gastroesophageal Junction Cancer: The JAVELIN Solid Tumor JPN Trial." Gastric Cancer 2018.
Style de citation MLADoi, Toshihiko, et al. "Phase 1 Trial of Avelumab (anti-PD-L1) in Japanese Patients With Advanced Solid Tumors, Including Dose Expansion in Patients With Gastric or Gastroesophageal Junction Cancer: The JAVELIN Solid Tumor JPN Trial." Gastric Cancer 2018.